Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,031 GBX | +0.06% | +6.78% | +13.51% |
03:34pm | ASTRAZENECA : Deutsche Bank gives a Neutral rating | ZD |
04-29 | J&J, Bristol Myers lose challenges to US drug price negotiation program | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.51% | 234B | |
+36.09% | 664B | |
+28.99% | 567B | |
-7.15% | 354B | |
+19.35% | 330B | |
+4.22% | 286B | |
+5.14% | 199B | |
-10.06% | 196B | |
-4.82% | 148B | |
-10.92% | 145B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Imfinzi Cocktail Improves Survival in Phase 3 Lung Cancer Study